Preclinical

Blending human knowhow, artificial intelligence aids drug discovery

02-Aug-2022 By Jenni Spinner

A leader from pharmaceutical firm Astellas discusses how the company has put to use a discovery platform that combines human expertise, AI, and robotics.

Cancer Moonshot meeting brings together survivors, industry leaders

26-Jul-2022 By Jenni Spinner

The gathering, convened by patient advocacy group Fight Colorectal Cancer, responded to President Biden’s call to improve screening and treatment options.

Collaboration sets sights on acceleration of cystic fibrosis research

20-Jul-2022 By Jenni Spinner

Epistemic AI, Cincinnati Children’s Hospital Medical Center, and Boomer Esiason Foundation are working together to advance research into the rare disease.

Lymphoma Research Foundation awards $5.7m to pursue blood cancer treatments

12-Jul-2022 By Jenni Spinner

The organization has given 29 research grants to scientists representing 17 different US institutions pursuing lymphoma treatments and cures in their work.

Precision medicine advancements good news for drug development

12-Jul-2022 By Jenni Spinner

A leader from healthcare commercial intelligence company Definitive Healthcare discusses the rise of precision medicine and the benefits the field can yield.

Sema4, Avera Health partner on precision cancer care initiative

07-Jul-2022 By Jenni Spinner

The health care system and analytics company are joining on the ASAP study, a program that constitutes a five-year commitment to advancing cancer solutions.

Indiana University Health enlists LifeOmic platform for cancer research

06-Jul-2022 By Jenni Spinner

The academic research center has adopted the life science technology company’s cloud-based platform for cancer research, drug discovery, and clinical trials.

AstraZeneca to buy blood cancer focused biotech in deal valued at up to $1.27bn

05-Jul-2022 By Jane Byrne

AstraZeneca is to acquire US-based blood cancer specialist, TeneoTwo, in a deal worth around US$1.27bn.

Lilly enlists Sidekick for breast cancer digital therapeutic

30-Jun-2022 By Nick Taylor

The pharmaceutical firm will work with the health tech company to create a digital therapeutic intended for patients dealing with a breast cancer diagnosis.

Gates Foundation to fund pediatric brain research in low-income areas

28-Jun-2022 By Jenni Spinner

The Bill and Melinda Gates Foundation grant, awarded to data management platform Flywheel, will support pediatric brain development in impoverished areas.

Sanofi pushes to accelerate medical writing, reporting processes

27-Jun-2022 By Nick Taylor

The pharmaceutical company has enlisted the help of the AI and NLP tech specialist to streamline clinical study report generation and submission processes.

The Method rolls out experience for living as a Type 2 diabetes patient for a day

27-Jun-2022 By Nick Taylor

The company has added Type 2 diabetes to the list of conditions it simulates in it’s A Life in a Day program, enabling people to spend a day living as if they have the disease.

Survey: most people believe in need for more cancer research

21-Jun-2022 By Jenni Spinner

A new survey reveals the majority of the general public thinks more cancer research is in order, but many are reluctant to pitch in to the effort financially.

Tech Innovations: June 2022

16-Jun-2022 By Jenni Spinner

This month’s announcements on new products, enhanced technology, partnerships, and more includes Eversana, Thermo Fisher Scientific, and other notable companies.

Innovative Trials partners with MS Society on multiple sclerosis R&D

13-Jun-2022 By Nick Taylor

The patient recruitment solutions company plans to work with the charity to support research and clinical trials through a range of fundraising activities.

dia 2022

Collaboration, innovation to take center stage at DIA 2022

08-Jun-2022 By Jenni Spinner

This year’s DIA Global Annual Meeting (taking place June 19-23 in Chicago) reunites professionals for face-to-face learning and networking opportunities.

dia 2022

DIA offers tracks to deliver focused educational experience

08-Jun-2022 By Jenni Spinner

Offering 13 topic tracks to choose from, the DIA Global Annual Meeting (scheduled June 19-23) lets attendees chose the path that fits their unique interests.

bio international 2022

BIO International 2022 to bring insights, athletes to San Diego

06-Jun-2022 By Jenni Spinner

Coming back to the real world June 13-16, the industry event will offer face-to-face learning, networking opportunities, and fun, star-studded opportunities.

Danish National Genome Center, Lifebit form personalized medicine partnership

01-Jun-2022 By Jenni Spinner

The Lifebit CloudOS will be employed to create a Federate Trusted Research Environment within the center’s supercomputing cluster to handle data management.

How Lithuania aims to become a leading European biotech hub

01-Jun-2022 By Ben Hargreaves

Lithuania’s life sciences industry is growing at one of the fastest rates in Europe. Ahead of BIO, Innovation Agency Lithuania explains what the country’s plans are for future growth in the area and how this is built upon students heading into STEM studies.

Lithuanian CDMO to open facility in Boston

25-May-2022 By Jane Byrne

Northway Biotech, a contract development and manufacturing organization (CDMO) based out of Vilnius, Lithuania, is set to open a facility in Boston, US.

Standigm uses AI to discover potential Crohn’s disease treatment

24-May-2022 By Jenni Spinner

The drug company, which uses artificial intelligence to discover and advance repurposed drugs, is harnessing the technology to find a treatment for Crohn’s.

Dermatology drug developer taps into Veeva engagement tool

23-May-2022 By Jenni Spinner

With Veeva Link for Key People, LEO Pharma is looking to deepen its efforts to engage with knowledgeable medical professionals in the dermatology community.

Industry pros thankful, hopeful on Clinical Trials Day 2022

19-May-2022 By Jenni Spinner

Experts and organizations are honoring the occasion (designed to celebrate research accomplishments and achievements) with insights, education, and more.

Machine learning can unlock potential of EEG data: Beacon Biosignals

18-May-2022 By Jenni Spinner

A leader from the neurobiomarker platform provider tells how use of ML and other advanced analytical tools can help make better use of complex information.

Artificial intelligence stands to transform precision medicine: AiCure

18-May-2022 By Jenni Spinner

An expert from the AI-focused technology company shares insights as to how it can be harnessed to better interpret, and even predict, patient behavior.

University of California at Irvine launches Institute for Precision Health

18-May-2022 By Jenni Spinner

The institute will combine the university’s AI, ML, health science, engineering, genomics, and data capabilities to tackle health strategy and inequity.

Lilly deploys AI-powered tech to expedite drug approval process

18-May-2022 By Jenni Spinner

The pharmaceutical company is partnering with Yseop to install the software company’s Augmented Analyst, designed to elevate and accelerate data analysis.

Breast cancer trial patient participants younger than ever: Phesi

16-May-2022 By Jenni Spinner

The company’s analysis of 2.5m patients worldwide suggest a growing proportion of younger patients, with implications for future study design and deployment.

Charles River, Valo join on AI-enabled drug discovery offering

10-May-2022 By Nick Taylor

The CRO has paired with the drug discovery technology firm on Logica, an artificial intelligence tool designed to accelerate development of new treatments.

Takeda joins with Xavier University to increase equity in healthcare

09-May-2022 By Jenni Spinner

The pharmaceutical firm and university have launched T-REX, a multi-year partnership focused on increasing health outcomes for underrepresented populations.

Illumina secures drug discovery tie-ups with Janssen, Deerfield

09-May-2022 By Jane Byrne

Illumina has recently announced a 10-year-long strategic collaboration with Janssen Biotech, and a five-year partnership with Deerfield Management.

People on the Move: May 2022

05-May-2022 By Jenni Spinner

This month’s news on partnerships, appointments, expansions, and investment includes Javara, ACG, Phastar, Elligo Health Research, and other notable companies.

AI use in life science not yet at full potential: IBM Research

03-May-2022 By Jenni Spinner

Leaders from the R&D tech company weigh in on how use of artificial intelligence has grown, ongoing challenges to effective adoption, and what lies ahead.

Pistoia Alliance calls for more pharma-patient collaboration in early R&D

02-May-2022 By Jenni Spinner

A leader from the life-science organization discusses how collaboration could lead to a broad range of benefits for everyone along the drug discovery pipeline

Vocal biomarker use can elevate patient monitoring: Sonde Health

28-Apr-2022 By Jenni Spinner

A leader from the health tech company explains how voice-based technologies could transform monitoring of patients with dementia, Alzheimer’s, and other conditions.

Sionna raises $111m to take molecules against CF target into the clinic

28-Apr-2022 By Nick Taylor

Newly launched life sciences company Sionna Therapeutics has secured funding to fuel discovery and development of drug candidates to treat cystic fibrosis.

CMC lands funding to develop treatment for nerve agent poisoning

19-Apr-2022 By Jenni Spinner

The CDMO has been awarded funding from the US government to work on treatments for sarin and other substances used frequently employed in chemical attacks.

RWE can boost trial acceleration, cost efficiency, and inclusivity

13-Apr-2022 By Jenni Spinner

An expert from trial tech specialist Komodo Health talks about how real-world evidence use could elevate study design, conserve costs, and improve recruitment.

UK-based collaborators to create world’s largest cancer database

12-Apr-2022 By Jenni Spinner

The partnership among three research and data specialists is aimed at creating a global database to support faster development of novel cancer treatments.

Former Johnson & Johnson, Bristol Myers Squibb executive to lead COTA

12-Apr-2022 By Jenni Spinner

Miruna Sasu has been named president and CEO of the company, which uses RWD and analytics in advancing oncology drug development and clinical trial diversity.

Winterlight Labs pitches in on decentralizing Alzheimer’s research

11-Apr-2022 By Jenni Spinner

The biomarker developer is partnering with Alzheimer Center Amsterdam on decentralized assessment of patient cognition and function in preclinical research.

People on the Move: April 2022

11-Apr-2022 By Jenni Spinner

This month’s news includes hiring, promotions, expansions, and acquisitions at H Clinical, Charles River, DHL Supply Chain, X-Chem, and other key companies.

Cancer researcher nabbed for falsifying data in PHS-funded grants

07-Apr-2022 By Jenni Spinner

The US Department of Health and Human Service’s Office of Research Integrity has uncovered evidence that Toni Brand committed fraud in a number of reports.

Innovative Purdue research leads to FDA-approved prostate cancer treatment

31-Mar-2022 By Jenni Spinner

A renowned university researcher explains the path that laid the foundation and what the novel diagnostic and treatment means for prostate cancer patients.

Roche, BMS to partner on personalized solutions for cancer patients

28-Mar-2022 By Jenni Spinner

The companies plan to work on developing personalized care solutions via digital pathology to come up with treatment options for patients with solid tumors.

The right tech can fill gap between lab scientist and data: ACD/Labs

16-Mar-2022 By Jenni Spinner

An expert from the R&D tech provider discusses how automation, integration, and other tools can help with effective access and analysis of lab information.

AbbVie, Gedeon Richter to partner on developing neuropsychiatric drugs

15-Mar-2022 By Jenni Spinner

The US- and Hungary-based pharma firms will work on research, development, and commercialization of dopamine receptor modulators for potential treatments.

Pharma leaders should step up on artificial intelligence: ConcertAI

14-Mar-2022 By Jenni Spinner

An executive from the AI specialist discusses how recent advances have provided opportunities for industry professionals to champion new ways of thinking.

Enveric taps University of Calgary to study psychedelic therapy in cancer-related distress

14-Mar-2022 By Nick Taylor

The pharma company and academic institution will explore the viability of a psychedelic treatment to help patients suffering from cancer-related distress.